Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthieu Resche-Rigon

Showing results (11-20 of 198) with videos related to

Pageof 20
Sort By:
Clinical Trials (London, England)|November 26, 2008
Adaptive designs for dose-finding in non-cancer phase II trials: influence of early unexpected outcomesMatthieu Resche-Rigon, Sarah Zohar, Sylvie Chevret
Clinical Neurology and Neurosurgery|February 10, 2015
Dual anticonvulsant and neuroprotective effects of therapeutic hypothermia after status epilepticusStéphane Legriel, Matthieu Resche-Rigon, Alain Cariou
Clinical Neurology and Neurosurgery|October 1, 2020
Neurofibromatosis type 2: A nationwide population-based study focused on survival after meningioma surgeryCharles Champeaux-Depond, Joconde Weller, Matthieu Resche-Rigon
Intensive Care Medicine|November 27, 2013
Old wine in new bottles: should we publish old data?Matthieu Resche-Rigon, Daniel Talmor, John P Kress
Statistics in Medicine|September 9, 2006
Analysing multicentre competing risks data with a mixed proportional hazards model for the subdistributionSandrine Katsahian, Matthieu Resche-Rigon, Sylvie Chevret, et al.
Critical Care (London, England)|May 11, 2013
Simple screening statistical tools to detect reporting bias: when should we ask for raw data?Romain Pirracchio, Matthieu Resche-Rigon, Sylvie Chevret, et al.
Annals of Intensive Care|September 6, 2013
Do simple screening statistical tools help to detect reporting bias?Romain Pirracchio, Matthieu Resche-Rigon, Sylvie Chevret, et al.
Acta Neurochirurgica|November 11, 2019
Intracranial WHO grade I meningioma: a competing risk analysis of progression and disease-specific survivalCharles Champeaux, Deborah Houston, Laurence Dunn, et al.
Journal of Clinical Epidemiology|June 8, 2015
A new weighted balance measure helped to select the variables to be included in a propensity score modelEmmanuel Caruana, Sylvie Chevret, Matthieu Resche-Rigon, et al.
Statistics in Medicine|February 20, 2016
A multiple imputation approach for MNAR mechanisms compatible with Heckman's modelJacques-Emmanuel Galimard, Sylvie Chevret, Camelia Protopopescu, et al.
Pageof 20

Showing results (11-20 of 198) with videos related to

Sort By:
Pageof 20
Clinical Trials (London, England)|November 26, 2008
Adaptive designs for dose-finding in non-cancer phase II trials: influence of early unexpected outcomesMatthieu Resche-Rigon, Sarah Zohar, Sylvie Chevret
Clinical Neurology and Neurosurgery|February 10, 2015
Dual anticonvulsant and neuroprotective effects of therapeutic hypothermia after status epilepticusStéphane Legriel, Matthieu Resche-Rigon, Alain Cariou
Clinical Neurology and Neurosurgery|October 1, 2020
Neurofibromatosis type 2: A nationwide population-based study focused on survival after meningioma surgeryCharles Champeaux-Depond, Joconde Weller, Matthieu Resche-Rigon
Intensive Care Medicine|November 27, 2013
Old wine in new bottles: should we publish old data?Matthieu Resche-Rigon, Daniel Talmor, John P Kress
Statistics in Medicine|September 9, 2006
Analysing multicentre competing risks data with a mixed proportional hazards model for the subdistributionSandrine Katsahian, Matthieu Resche-Rigon, Sylvie Chevret, et al.
Critical Care (London, England)|May 11, 2013
Simple screening statistical tools to detect reporting bias: when should we ask for raw data?Romain Pirracchio, Matthieu Resche-Rigon, Sylvie Chevret, et al.
Annals of Intensive Care|September 6, 2013
Do simple screening statistical tools help to detect reporting bias?Romain Pirracchio, Matthieu Resche-Rigon, Sylvie Chevret, et al.
Acta Neurochirurgica|November 11, 2019
Intracranial WHO grade I meningioma: a competing risk analysis of progression and disease-specific survivalCharles Champeaux, Deborah Houston, Laurence Dunn, et al.
Journal of Clinical Epidemiology|June 8, 2015
A new weighted balance measure helped to select the variables to be included in a propensity score modelEmmanuel Caruana, Sylvie Chevret, Matthieu Resche-Rigon, et al.
Statistics in Medicine|February 20, 2016
A multiple imputation approach for MNAR mechanisms compatible with Heckman's modelJacques-Emmanuel Galimard, Sylvie Chevret, Camelia Protopopescu, et al.
Pageof 20